Explore

Advertise on Engormix

The use of monovalent or bivalent IBV vaccines significantly reduces clinical signs but not viral load after heterologous challenge

Published: January 7, 2021
Summary
...
Content from the event:
Related topics:
Authors:
Dr. Brian Jordan
Deborah Hilt
Dr. Mark Jackwood
Recommend
Comment
Share
MADHUSUDHAN.K.N
3 de marzo de 2020
Thanks for updating us
Recommend
Reply
1
Profile picture
Would you like to discuss another topic? Create a new post to engage with experts in the community.
Featured users in Poultry Industry
Fernanda Castro
Fernanda Castro
Micronutrition and Health Technical Lead
United States
Ana Maria Villegas-Gamble
Ana Maria Villegas-Gamble
DVM, MS, Ph.D. / Directora de Nutrición
United States
Kim Litteken
Kim Litteken
Marketing and Customer Service Manager
United States
The use of monovalent or bivalent IBV vaccines significantly reduces clinical signs but not viral load after heterologous challenge | Engormix